Skip to main content

Jeevasa USA

REGENERATIVE MEDICINE • ARTHRITIS CARE

Stem Cell Therapy
for Arthritis

Stem Cell Therapy for Arthritis at Jeevasa USA combines regenerative medicine, personalized medical evaluation and comprehensive joint care for carefully selected patients with osteoarthritis and other forms of arthritis. Each care plan is developed around the affected joints, disease type, mobility, medical history and long-term health goals.

Explore Your Treatment Options

Speak with our regenerative medicine team to understand whether Stem Cell Therapy may be suitable for your condition.

Understanding
Arthritis & Osteoarthritis

Arthritis is a broad term for conditions affecting the joints, surrounding tissues and connective structures. Common symptoms include joint pain, stiffness, swelling and reduced movement, although the symptoms and underlying causes can differ considerably between patients.

Osteoarthritis is the most common form of arthritis. It is a degenerative joint condition in which tissues within the joint gradually break down, frequently affecting the knees, hips, hands and spine. Rheumatoid arthritis is different: it is a chronic autoimmune disease in which the immune system attacks the body’s tissues, causing inflammation, pain, stiffness and joint dysfunction.

Identifying the specific type of arthritis is essential because osteoarthritis, rheumatoid arthritis and other joint conditions require different investigations, clinical management and long-term care pathways.

Mobility

Pain and Stiffness

Joint Structure

Comprehensive Arthritis Care
Goes Beyond Pain Relief

Managing arthritis involves more than reducing pain alone. Long-term care focuses on supporting joint function, improving mobility, maintaining strength, preserving independence and reducing the condition’s impact on everyday life through personalized medical care.

Explore Your Treatment Options

Speak with our regenerative medicine team to understand whether Stem Cell Therapy may be suitable for your condition.

Could Regenerative Medicine Be Appropriate for Arthritis?

At Jeevasa USA, regenerative medicine may be considered for carefully evaluated patients with osteoarthritis and selected arthritis-related joint concerns. Every recommendation begins with a comprehensive clinical assessment, medical-history review, imaging evaluation and analysis of current joint function.

For rheumatoid arthritis, specialist evaluation is particularly important because it is an autoimmune inflammatory disease and its management differs from degenerative osteoarthritis.

Individual Evaluation

Assessment of symptoms, mobility, imaging and medical history

Personalized Care Plan

Recommendations designed around your arthritis type & goal

Stem Cell Therapy

Explored where clinically appropriate under specialist supervision

Long-Term Joint Care

Ongoing rehabilitation, monitoring and personalized follow-up

Common Challenges Associated With Arthritis

Persistent Joint Pain

Joint Stiffness

Joint Swelling

Reduced Mobility

Muscle Weakness

Reduced independence

Lower Endurance

Your Journey With Jeevasa

Consultation

Advanced Evaluation

Treatment Plan

Stem Cell Therapy

Recovery Support

Long-Term Follow-Up

Why Patients Choose Jeevasa for Arthritis

Research Driven Process

Advancing regenerative medicine through innovation.

Experienced Medical Team

Multidisciplinary professionals for arthritis care

Advanced Technology

Modern facilities supporting safe clinical protocols.

Personalized Care Plan

Care pathways designed around individual goals.

Global Patient Support

Dedicated assistance for patients from India and overseas.

Comprehensive Arthritis Care

Focused on mobility, function and long-term rehabilitation.

Conditions We Also Support

FAQ

Stem Cell Therapy for Arthritis refers to a regenerative-medicine approach that may be evaluated for selected patients as part of a broader joint-care plan. Suitability depends on the type of arthritis, affected joint, disease severity, imaging findings and overall health.

It may be considered for selected patients with osteoarthritis following clinical examination and review of imaging, symptoms, mobility and previous treatment. A specialist must determine whether the approach is appropriate for the individual patient.

Yes. Osteoarthritis is primarily a degenerative joint condition involving the breakdown of joint tissues. Rheumatoid arthritis is an autoimmune inflammatory disease in which the immune system attacks the body’s tissues.

Rheumatoid arthritis requires specialist rheumatology care because it is an autoimmune disease. Regenerative medicine should not be presented as a replacement for prescribed medicines or disease-modifying treatment. Any additional intervention requires careful multidisciplinary evaluation.

Eligibility depends on the confirmed diagnosis, affected joints, severity of symptoms, imaging findings, medical history, current medicines and overall health. A detailed specialist evaluation is required before any recommendation is made.

 

View all FAQ

Evaluation may include clinical examination, X-rays, MRI or ultrasound, laboratory reports, medication history and mobility assessment. Rheumatoid arthritis evaluation may also involve inflammatory and autoimmune markers where clinically indicated.

Yes. A comprehensive approach may include mobility exercises, muscle strengthening, activity guidance, physiotherapy and long-term follow-up according to the patient’s condition and functional goals.

Osteoarthritis commonly affects the knees, hips, hands, neck and lower back, although it can affect other joints. Symptoms frequently include pain, stiffness, swelling and reduced movement

Yes. International patients can share their medical records, imaging and treatment history for an initial review before planning travel to Jeevasa Hospitals in Mohali, Chandigarh Tricity, Punjab, India.

Complete the website enquiry form or contact Jeevasa USA to arrange an initial consultation. Available medical reports and joint-imaging records should be shared to support an informed clinical review.

View all FAQ

Trusted by Patients Worldwide

25+

Years of Research & Clinical Experience

10,000+

Patients Supported Worldwide

15+

Countries Served

Research

Institute of Longevity Research